MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors

Drug and Chemical Toxicology

Volumn 34, Issue 1, 2011, Pages 45-52

  You, Bo Ra ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; CPAEC; GSH; MAPK inhibitor; MG132; ROS

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CALF PULMONARY ARTERY ENDOTHELIAL CELL; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; DNA EXTRACTION; ENDOTHELIUM CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CATTLE; CELL CULTURE TECHNIQUES; CELL DEATH; CELL LINE; CELL PROLIFERATION; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUTATHIONE; LEUPEPTINS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE INHIBITORS; PULMONARY ARTERY; REACTIVE OXYGEN SPECIES;

EID: 78649911530     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2010.494663     Document Type: Article

References (26)

1. Bassenge, E. (1996). Endothelial function in different organs. Prog Cardiovasc Dis 39:209-228.
2. Blenis, J. (1993). Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci U S A 90:5889-5892.
3. Chen, T. J., Jeng, J. Y., Lin, C. W., Wu, C. Y., Chen, Y. C. (2006). Quercetin inhibition of ROS-dependent and-independent apoptosis in rat glioma C6 cells. Toxicology 223:113-126.
4. Dasmahapatra, G., Rahmani, M., Dent, P., Grant, S. (2006). The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 107:232-240.
5. Estrela, J. M., Ortega, A., Obrador, E. (2006). Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143-181.
6. Genestra, M. (2007). Oxyl radicals, redox-sensitive signalling cascades, and antioxidants. Cell Signal 19:1807-1819.
7. Gomez-Lazaro, M. Galindo, M. F. Melero-Fernandez de Mera, R. M. Fernandez-Gomez, F. J. Concannon, C. G. Segura, M. F. Comella, J. X. Prehn, J. H. Jordan, J. (2007). Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate. Mol Pharmacol 71:736-743.
8. 2. Role in cell survival following oxidant injury. J Biol Chem 271:4138-4142.
9. Han, Y. H., Kim, S. H., Kim, S. Z., Park, W. H. (2008a). Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int J Oncol 33:1099-1105.
10. Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2007). Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am J Physiol Renal Physiol 293: F511-F520.
11. Han, Y. H., Kim, S. Z., Kim, S. H., Park, W. H. (2008b). Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer 59:301-314.
12. Henson, E. S., Gibson, S. B. (2006). Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 18:2089-2097.
13. Higuchi, Y. (2004). Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. J Cell Mol Med 8:455-464.
14. Hsin, Y. H., Chen, C. F., Huang, S., Shih, T. S., Lai, P. S., Chueh, P. J. (2008). The apoptotic effect of nanosilver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 179:130-139.
15. Jahngen-Hodge, J., et al. (1997). Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem 272:28218-28226.
16. + exchange and ERK1/2. Circ Res 83:824-831.
17. Lee, D. H., Goldberg, A. L. (1998). Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 8:397-403.
18. Ling, Y. H., Liebes, L., Zou, Y., Perez-Soler, R. (2003). Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small-cell lung cancer cells. J Biol Chem 278:33714-33723.
19. Mao, X., Yu, C. R., Li, W. H., Li, W. X. (2008). Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res 18:879-888.
20. Orlowski, R. Z. (1999). The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ 6:303-313.
21. Park, W. H., et al. (2000). Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60:3065-3071.
22. Perez-Galan, P., Roue, G., Villamor, N., Montserrat, E., Campo, E., Colomer, D. (2006). The proteasome inhibitor, bortezomib, induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107:257-264.
23. Qiu, J. H., Asai, A., Chi, S., Saito, N., Hamada, H., Kirino, T. (2000). Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J Neurosci 20:259-265.
24. Rygiel, T. P., Mertens, A. E., Strumane, K., van der Kammen, R., Collard, J. G. (2008). The Rac activator, Tiam1, prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation. J Cell Sci 121:1183-1192.
25. Voges, D., Zwickl, P., Baumeister, W. (1999). The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015-1068.
26. Wu, H. M., Chi, K. H., Lin, W. W. (2002). Proteasome inhibitors stimulate activator protein-1 pathway via reactive oxygen species production. FEBS Lett 526:101-105.